U.S. federal trademark · Serial No. 86288618 · Reg. No. 012458931
[ Pharmaceutical and medicinal preparations for the treatment of viral infections, cancer and pre-cancerous disorders; active pharmaceutical substances based on synthetic long peptides which may be modified to improve the immune response and may be combined with other pharmaceutical products for the treatment of viral infections, cancer and pre-cancerous disorders; immune response adjuvants for medical purposes; pharmaceutical compounds for treating viral infections, cancer and pre-cancerous disorders by means of immune system modulation ]
Medical services in the biotechnological and pharmaceutical field and in the field of immunotherapy
Scientific and technological services and research and design relating thereto in the biotechnological, chemical and pharmaceutical field and in the field of immunotherapy; industrial analysis, namely, analysis of the design, manufacturing and development of immunotherapy pharmaceuticals; research services in the field of pharmaceuticals; scientific research and development services in the biotechnological, chemical and pharmaceutical field and in the field of immunotherapy
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.